Skip to main content

Table 1 Clinical characteristics and follow-up data of 19 patients with GCP

From: Computed tomography features and clinical characteristics of gastritis cystica profunda

No

Sex

Age

Symptom and duration

Treatment history

Hyper-tension

Smoking

Fecal occult blood test

CEA

AFP

CA125

CA199

Operation

Pathologic diagnosis

Follow-up period (months)

Recurrence

1

F

32

Epigastric pain or distension 10D

Gastrectomy

GCP

93

2

M

64

Epigastric pain or distension 60D

+

ESD

GCP with low-grade epithelial dysplasia

69

3

F

55

Epigastric pain or distension 20D

NA

Gastrectomy

GCP

63

4

F

61

Dysphagia 15D

Gastric polypectomy

Gastrectomy

GCP

46

5

F

44

Nausea or vomiting 92D

NA

NA

ESD

GCP with heterotopic pancreas

46

6

F

62

Detect lesions by accident 1D

EMR

GCP

38

7

M

67

Dysphagia and acid reflux 30D

+

ESD

GCP

42

8

F

64

Nausea or vomiting 5D

+

EMR

GCP with high-grade epithelial dysplasia

39

NA

9

F

57

Nausea or vomiting 120D

ESD

GCP

37

NA

10

F

49

Epigastric pain or distension 20D

EMR

GCP

31

11

M

54

Hematemesis and melena 15D

+

NA

Gastrectomy

GCP

30

12

M

53

Abnormal defecation 6D

NA

EMR

GCP

20

13

F

70

Abnormal defecation 30D

+

+

ESD

GCP

17

14

F

76

Epigastric pain or distension 60D

+

NA

EMR

GCP

15

15

F

55

Hematemesis 10D

+

NA

EMR

GCP

13

NA

16

M

30

Acid reflux and heartburn 30D

+

NA

ESD

GCP

12

17

M

34

Epigastric pain or distension 15D

NA

ESD

GCP accompanied by adenocarcinoma

8

18

M

67

Detect lesions by accident 9D

EMR

GCP

8

19

M

61

Epigastric pain or distension 5D

ESD

GCP

6

  1. GCP, gastritis cystica profunda; M, male; F, female; CEA, carcinoembryonic antigen (positive defined as > 5 U/mL); AFP, alpha fetoprotein (positive defined as > 10 U/mL); CA125, carbohydrate antigen 125 (positive defined as > 35 U/mL); CA199, carbohydrate antigen 199 (positive defined as > 35 U/mL); ESD, endoscopic submucosal dissection; EMR, endoscopic mucosal resection; + , yes/present/positive; −, no/absent/negative; NA, not available